SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a - 16 OR 15d - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of July, 2003
SkyePharma PLC, 105 Piccadilly, London W1J 7NJ England
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______
Immediate Release 7 July 2003 SkyePharma PLC Application has been made to the London Stock Exchange and to the UK Listing Authority for the admission of 3,820,231 ordinary shares of 10p each, ranking pari passu with the current issued share capital, to the Official List. These shares have been allotted in connection with the following:- 1. 3,690,211 Ordinary Shares in aggregate have been allotted by way of deferred consideration in connection with the agreement for the acquisition by the Company of RTP Pharma Inc.. In consideration for the loss of certain option rights by shareholders of RTP Pharma Inc., the Company is required to issue 200,000 additional shares, or pay an amount in cash, for each penny difference between the actual share price at 30 June 2003, as calculated in accordance with the terms of the agreement, and 82 pence. 2. 130,020 ordinary shares in aggregate have also been allotted in connection with the exercise of Employee Share Options as follows:- 13 June 2003 113,395 ordinary shares 19 June 2003 10,125 ordinary shares 26 June 2003 6,500 ordinary shares It is anticipated that these shares will be listed on the Official List of the UK Listing Authority and traded on the London Stock Exchange PLC on Thursday 10th July 2003. Copies of this announcement are available, free of charge, from:- MERRILL LYNCH INTERNATIONAL 20 FARRINGDON ROAD LONDON EC1M 3NH
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By: /s/ Douglas Parkhill
Name: Douglas Parkhill
Title: Company Secretary
Date: July 7, 2003